These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8371235)

  • 21. Immunoglobulin A and C reactive protein levels in ankylosing spondylitis.
    Collado A; Sanmarti R; Brancós MA; Kanterewicz E; Gallart T; Rotés-Querol J; Cobos A
    Ann Rheum Dis; 1987 Sep; 46(9):719-20. PubMed ID: 3675018
    [No Abstract]   [Full Text] [Related]  

  • 22. [Painful edema of the feet revealing ankylosing spondylitis].
    Marquart-Elbaz C; Lipsker D; Sibilia J; Faivre M; Grosshans E; Cribier B
    Ann Dermatol Venereol; 2002; 129(6-7):889-91. PubMed ID: 12218918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.
    Park MC; Lee SW; Choi ST; Park YB; Lee SK
    Scand J Rheumatol; 2007; 36(2):101-6. PubMed ID: 17476615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveitis screening: HLAB27 antigen and ankylosing spondylitis in a New Zealand population.
    Niederer R; Danesh-Meyer H
    N Z Med J; 2006 Mar; 119(1230):U1886. PubMed ID: 16532040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in natural immunity in the blood in ankylosing spondylarthritis].
    Hrncír Z; Krupar V; Tichý M
    Vnitr Lek; 1984 Feb; 30(2):116-24. PubMed ID: 6609483
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis.
    Yang C; Gu J; Rihl M; Baeten D; Huang F; Zhao M; Zhang H; Maksymowych WP; De Keyser F; Veys EM; Yu DT
    Arthritis Rheum; 2004 Oct; 51(5):691-9. PubMed ID: 15478146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum testosterone levels are not elevated in patients with ankylosing spondylitis.
    Giltay EJ; Popp-Snijders C; van Schaardenburg D; Dekker-Saeys BJ; Gooren LJ; Dijkmans BA
    J Rheumatol; 1998 Dec; 25(12):2389-94. PubMed ID: 9858435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antiphospholipid antibodies in patients with ankylosing spondylitis.
    Juanola X; Mateo L; Domenech P; Bas J; Contreras N; Nolla JM; Roig-Escofet D
    J Rheumatol; 1995 Oct; 22(10):1891-3. PubMed ID: 8991987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH; Lee HJ; Sung IH; Kim TH
    J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genetic basis of ankylosing spondylitis.
    Reveille JD
    Curr Opin Rheumatol; 2006 Jul; 18(4):332-41. PubMed ID: 16763451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-TNF alfa therapy in ankylosing spondylitis].
    Cravo AR; Tavares V; Da Silva JC
    Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis.
    de Vries MK; van der Horst-Bruinsma IE; Nurmohamed MT; Aarden LA; Stapel SO; Peters MJ; van Denderen JC; Dijkmans BA; Wolbink GJ
    Ann Rheum Dis; 2009 Apr; 68(4):531-5. PubMed ID: 18375542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis.
    Imrich R; Rovensky J; Zlnay M; Radikova Z; Macho L; Vigas M; Koska J
    Ann Rheum Dis; 2004 Jun; 63(6):671-4. PubMed ID: 15140773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of etanercept for treating ankylosing spondylitis].
    Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of morphological changes in proximal femur on prosthesis selection of total hip arthroplasty in patients with ankylosing spondylitis].
    Yang P; Wang C; Wang K
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Apr; 20(4):448-50. PubMed ID: 16683454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma J; Cardon LR; Bradbury L; Brophy S; van der Horst-Bruinsma I; Calin A; Brown MA
    Arthritis Rheum; 2001 Jun; 44(6):1396-400. PubMed ID: 11407700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological and clinical markers of disease activity in ankylosing spondylitis.
    Muñoz-Villanueva MC; Muñoz-Gomariz E; Escudero-Contreras A; Pèrez-Guijo V; Collantes-Estévez E
    J Rheumatol; 2003 Dec; 30(12):2729-32. PubMed ID: 14719229
    [No Abstract]   [Full Text] [Related]  

  • 39. Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis.
    Howe HS; Cheung PL; Kong KO; Badsha H; Thong BY; Leong KP; Koh ET; Lian TY; Cheng YK; Lam S; Teo D; Lau TC; Leung BP
    Rheumatology (Oxford); 2005 Jan; 44(1):51-4. PubMed ID: 15479754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genetics of cytokines in ankylosing spondylitis.
    Stone MA; Inman RD
    J Rheumatol; 2001 Jun; 28(6):1203-6. PubMed ID: 11409109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.